)
Vaxcyte (PCVX) investor relations material
Vaxcyte AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting called to order by the Chairman, with board members and key executives present.
Inspector of Election and representatives from Deloitte & Touche in attendance.
Voting procedures and eligibility clarified, with polls opened for voting.
Notice of meeting and affidavit of mailing incorporated into the minutes.
Shareholder proposals
Election of three Class III directors to serve until the 2029 Annual Meeting.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation as disclosed in the proxy statement.
Overview of voting outcomes
Quorum established with 95.13% of shares represented.
All board-recommended proposals passed according to preliminary voting results.
Results to be disclosed in a Form 8-K filing with the SEC.
- Pivotal adult vaccine data and a novel Group A Strep program position the pipeline for leadership.PCVX
Jefferies Global Healthcare Conference 20263 Jun 2026 - Broad-spectrum vaccines advance with robust data and global market expansion opportunities.PCVX
Corporate presentation3 Jun 2026 - VAX-31 aims for best-in-class pneumococcal coverage, with pivotal data expected Q4 2024.PCVX
Bank of America Global Healthcare Conference 202612 May 2026 - VAX-31 and VAX-24 aim to set new standards in pneumococcal disease coverage and market adoption.PCVX
Corporate presentation7 May 2026 - Q1 2026 net loss hit $320.6M; all VAX-31 trials enrolled, cash reserves at $2.74B.PCVX
Q1 20266 May 2026 - VAX-31 nears pivotal data and BLA filing as Group A Strep vaccine enters clinical trials.PCVX
Leerink Global Healthcare Conference 202629 Apr 2026 - Proxy covers director elections, auditor ratification, say-on-pay, and strong governance practices.PCVX
Proxy filing23 Apr 2026 - Annual meeting to elect directors, ratify auditor, and vote on executive pay June 15, 2026.PCVX
Proxy filing23 Apr 2026 - Late-stage clinical progress, manufacturing scale-up, and strong cash position drive 2026 outlook.PCVX
Q4 202517 Apr 2026
Next Vaxcyte earnings date
Next Vaxcyte earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)